May 13
|
Collegium Announces $35 Million Accelerated Share Repurchase Program
|
May 10
|
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
|
May 9
|
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
May 9
|
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
|
May 9
|
Collegium Reports First Quarter 2024 Financial Results
|
May 9
|
Collegium Announces CEO Transition
|
May 7
|
Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics
|
May 2
|
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Apr 29
|
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
|
Apr 29
|
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
|
Apr 25
|
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
|
Apr 17
|
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?
|
Apr 11
|
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
|
Apr 9
|
Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know
|
Apr 3
|
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
|
Mar 18
|
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
|
Mar 18
|
Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron
|
Mar 18
|
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
|
Mar 13
|
3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock
|
Jan 24
|
Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again
|